Invention Grant
- Patent Title: PDE III inhibitors for treatment of asymptomatic heart failure
-
Application No.: US16127921Application Date: 2018-09-11
-
Publication No.: US11413285B2Publication Date: 2022-08-16
- Inventor: Juergen Daemmgen , Olaf Joens , Rainer Kleemann , Christian Troetschel , Andrea Vollmar
- Applicant: Boehringer Ingelheim Vetmedica GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim Vetmedica GmbH
- Current Assignee: Boehringer Ingelheim Vetmedica GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Andrew Aldag; John Ezcurra
- Priority: EP04007179 20040325,EP05110689 20051114
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61P9/04 ; A61K31/4166 ; A61K31/4412 ; A61K31/4427 ; A61K31/444 ; A61K31/341 ; A61K31/40 ; A61K31/55 ; A61K31/7048
Abstract:
A method for treating a patient suffering from ISACHC Classification Class I heart failure includes administering to the patient a therapeutically effective amount of pimobendan or a pharmaceutically acceptable salt thereof, where the administration results in a reduction in the size of the patient's heart.
Public/Granted literature
- US20190008862A1 PDE III INHIBITORS FOR TREATMENT OF ASYMPTOMATIC HEART FAILURE Public/Granted day:2019-01-10
Information query
IPC分类:
